Environmental Health Symposium Showcases Occupational Health and Safety Research
CincinnatiScientists will discuss the latest occupational and environmental health research at the University of Cincinnati (UC) Education and Research Centers eighth annual Pilot Research Project Symposium on Thursday, Oct. 11, and Friday, Oct. 12
The symposium, which takes place at the UC College of Medicines Kresge Auditorium, is free and open to the public.
Led by Amit Bhattacharya, PhD, professor of environmental health, the Pilot Research Project seeks to increase the Tristate regions research capacity through collaboration with 12 universities and colleges. The program offers financial support to doctoral students and junior faculty with promising research ideas.
The center aims to increase the research capacity of trainees and young investigators in occupational health and safety, and to encourage those in related disciplines at collaborating universities throughout the region to pursue occupational health and safety research.
During the conference, the previous years research award winners will present their results, while 200708 winners will give a poster presentation of their proposed work.
Adedeji Badiru, PhD, of the Air Force Institute of Technology, will discuss a systems engineering view of global health care research and delivery during a keynote address on Oct. 11. Thomas Thundat, PhD, of Oak Ridge National Laboratory, will give a keynote address about nanomechanics and sensors on Oct. 12.
The symposium is free and open to the public. Continuing education units are available. For more information or to register, contact Sharon Smith at (513) 558-1730 or sharon.smith@uc.edu, Amber Twitty at (513) 558-5710 or amber.twitty@uc.edu, or go online to www.eh.uc.edu.
UC is one of only 16 NIOSH-funded Education and
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.